To fulfill the promise of precision medicine and to facilitate a deeper understanding of the biology of cancer and other complex diseases, Caris Life Sciences® has developed a patented and proprietary biotargeting system to identify novel molecular targets for drug development and advanced diagnostics.
Caris Life Sciences also pioneered the first comprehensive, technology agnostic, evidence-guided tumor profiling service. As the industry leader, Caris provides reliable and actionable information about a patient’s tumor that serves as a molecular blueprint to personalize cancer therapy and improve care.
J.P. Morgan Healthcare Conference
David D. Halbert, Chairman and Chief Executive Officer, presents at the 34th Annual J.P. Morgan Healthcare Conference.
Caris Foundation™ is making a difference today for thousands of people worldwide through empowerment, support and medical care.
Latest Scientific Publications
View the latest publications from Caris, as well as abstracts and posters presented to the clinical oncology community.
When the next step in treatment is uncertain, Caris Life Sciences illuminates a clearer path to personalized treatment selection through our industry leading tumor profiling service, Caris Molecular Intelligence. Also, learn how we are pioneering a new era in drug development and advanced diagnostics with our proprietary, blood-based ADAPT Biotargeting System platform.Visit Platforms Page
Although cancer treatments have significantly advanced over the years, current cancer care options are failing too many patients. It’s time to treat cancer smarter. An analysis of your cancer with tumor profiling may identify biomarkers that could lead towards a better understanding of what is causing your cancer to grow and inform personalized treatments to specifically target your cancer.Visit Patients Page
Latest News and Social Media Posts
As a leader in precision healthcare and informatics, Caris Life Sciences is continually exploring new technologies and partnering with other trailblazers in the field. We’re always excited to share our most recent accomplishments and discoveries.Visit News PortalSocial Media Posts